Drug Discovery

(Image: Getty/ Sandra Leidholdt)

Yale taps Genesis CRO for drug discovery services

By Maggie Lynch

Yale University is partnering with CROs to provide drug discovery services to awardees of the Blavatnik Fund for Innovation – which aims to bridge the gap between early-stage research and product development.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers